New Delhi [India], September 16 (ANI): Secretary, Department of Biotechnology, Government of India Dr Renu Swarup said that Drugs Controller General of India has given permission to Christian Medical College, Vellore to start a trial on the mixing of COVID-19 vaccines while adding that th
New Delhi [India], September 14 (ANI): The COVID-19 pandemic has posed many challenges, but the country has responded extremely well to all of them, said Dr Renu Swarup, Secretary of the Department of Biotechnology on Tuesday.
New Delhi [India], September 14 (ANI): The approval of Bharat Biotech's COVID-19 vaccine Covaxin for Emergency use Listing (EUL) from the World Health Organisation (WHO) is expected at any time soon, said Dr VK Paul, NITI Aayog member (Health) on Tuesday.
New Delhi [India], September 13 (ANI): The World Health Organisation's (WHO) approval for Bharat Biotech's COVID-19 vaccine, Covaxin, is expected this week, sources said on Monday.
New Delhi [India], September 8 (ANI): The All India Institute Of Medical Sciences (AIIMS) here will be starting Phase 2/3 trials of Hyderabad-based COVID-19 vaccine manufacturer Bharat Biotech's nasal vaccine soon, sources informed on Wednesday.
Washington [US], September 5 (ANI): A recent study by the North Carolina State University showed how a single mechanism can trigger different behaviours from the same gene -- and has applications in the biotechnology sector.
Bharuch (Gujarat) [India], August 29 (ANI): Union Minister of Health and Family Welfare, Mansukh Mandaviya on Sunday launched the first commercial batch of Bharat Biotech's COVAXIN manufactured in Gujarat's Ankleshwar.
New Delhi [India], August 25 (ANI/ThePRTree): Fermenta Biotech Limited ('Fermenta') announced that Prashant Nagre, Managing Director, has been recognized among India's Best Leaders in Times of Crisis 2021. This initiative by Great Place to Work India identifies organizations and their leader
Hyderabad (Telangana) [India], August 25 (ANI): The International Vaccine Institute (IVI) and Bharat Biotech on Wednesday announced the beginning of Phase II/III clinical trial of Chikungunya vaccine candidate (BBV87) in Costa Rica.
New Delhi [India], August 23 (ANI): Dr Renu Swarup, Director of the Department of Biotechnology on Monday said that the Government Of India (GOI) is working on vaccines with the needed modification to fight against any strain of COVID-19 i.e Pan-Corona Vaccine.
New Delhi [India], August 23 (ANI): The third Covid-19 wave will come if "invited" by the human behaviour and that of the virus, said Dr Renu Swarup, Secretary of Department of Biotechnology, Government of India, on Monday.
New Delhi [India], August 23 (ANI): The Drugs Controller General of India (DCGI) on Friday approved Zydus Cadila's DNA vaccine for emergency use in adults and children aged 12 years and above.